This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.
We are pleased to invite you to join the PCCS National Heart Failure with Preserved Ejection Fraction (HFpEF) Quality Improvement (QI) Programme: Leading change in primary care – a focused, multi‑webinar virtual series designed to strengthen confidence in the management of HFpEF and support positive clinical outcomes across primary care.
This four‑month educational journey brings together PCCS council faculty and national HF experts to explore the evolving HFpEF landscape, practical diagnostic approaches, multimorbidity management, integrated pathways and real-world quality improvement resources. The programme supports clinicians to embed evidence-based, holistic care in HFpEF management and drive measurable improvements at practice or primary care network (PCN) level.
This programme is endorsed by the British Society for Heart Failure.
Webinar schedule:
Across the series you will gain:
- Clear clinical grounding in HFpEF epidemiology, diagnosis, coding and multimorbidity
- A practical understanding of NHSE HFpEF guidance and modern therapeutic options
- Resources to review and interpret your practice/PCN HFpEF performance
- Insights into delivering holistic cardio‑renal‑metabolic care in relation to HFpEF
- Skills to plan, implement and evaluate a local HFpEF QI project
- Coaching from national experts to support poster development and abstract writing
Delivered live by the PCCS council faculty and invited national leaders in heart failure care.
The full agenda and speaker profiles can be seen on the tabs above.
What you can expect:
Across four focused webinars, you will experience:
- Concise, clinically relevant updates on HFpEF and related CVRM conditions
- Real examples of how practices and PCNs are improving HFpEF management
- Practical demonstrations of multimorbidity and holistic care approaches
- Live discussion with the expert faculty on challenges faced in daily practice
- A structured change‑management journey, supporting you to identify a local HFpEF improvement goal, apply QI tools, begin meaningful implementation
The series is designed to be practical, applicable and supportive of real-world primary care pressures.
We hope you are able to join us for this exciting new programme.
This programme is endorsed by the British Society for Heart Failure.
This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.
Agenda
Tuesday 7th July 2026
09:30
Welcome and Introduction
- Speaker: Prof Raj Thakkar
10:20
Session 1
What is HFpEF, epidemiology, coding and the impact on the NHS
- Speaker: Prof Raj Thakkar
11:00
Session 2
HFpEF as a multimorbid condition
11:50
Session 3
Understanding your practice or PCN performance
- Speaker: Prof Clare Taylor
12:30
Session 4
QI and igniting your change project – colleagues to showcase their change ideas
- Speaker: Prof Raj Thakkar
13:00
Closing remarks
- Speaker: Prof Raj Thakkar
Wednesday 9th September 2026
13:00
Welcome and introduction
- Speaker: Prof Raj Thakkar
13:05
Session 1
QI progress feedback – data and learns
- Speaker: Prof Raj Thakkar
13:45
Session 2
NHSE guideline on HFpEF
- Speaker: Dr Lisa Anderson
15:15
Session 3
Influence and credibility
- Speaker: Prof Raj Thakkar
16:00
Session 4
QI project – treatment-based QI
- Speaker: Prof Clare Taylor
16:30
Closing remarks
- Speaker: Prof Raj Thakkar
Monday 19th October 2026
09:30
Welcome and introduction
- Speaker: Prof Raj Thakkar
09:35
Session 1
QI feedback
- Speaker: Prof Raj Thakkar
10:15
Session 2
Hot topics in cardio-renal disease
- Speaker: Prof Patricia Campbell
11:45
Session 3
How to write an abstract
- Speaker: Prof Clare Taylor
12:30
Session 4
COPD and HF – missed opportunities
13:00
Closing remarks
- Speaker: Prof Raj Thakkar
Tuesday 17th November 2026
13:00
Welcome and introduction
- Speaker: Prof Raj Thakkar
13:05
Session 1
Lifestyle and HF care
- Speaker: Dr Sundhya Raman
13:45
Session 2
QI poster feedback and discussion
- Speaker: Prof Clare Taylor
15:15
Session 3
A holistic approach in CVRM medicine - Practical management
16:00
Session 4
Reflections, next steps and conclusions
16:30
Closing remarks
- Speaker: Prof Raj Thakkar
Agenda subject to change
This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.
Speakers
Prof Raj Thakkar
PCCS President and CKD representative
As President of the Primary Care Cardiovascular Society, Prof Raj Thakkar will serve a two-year term, representing the Society and guiding it in line with its aim and governance.
Working closely with the Board of Directors, Secretariat, and other key officers, the President leads strategic planning, chairs major meetings and conferences, and oversees succession and recruitment processes.
Externally, the President represents PCCS at national events and contributes to key healthcare initiatives, including NICE stakeholder engagement.
Dr Jim Moore
Past President of the Primary Care Cardiovascular Society, GP, GPSI Cardiology, Gloucestershire
Dr Moore is a GP in Gloucestershire with a special interest in Cardiovascular Medicine and Past President of the Primary Care Cardiovascular Society, spearheading significant changes in this organisation. He lectures extensively across the UK.
He has been heavily involved in National CVD advisory groups, guidelines and working parties. He was a member of the NICE Chronic Heart Failure in Adults Guideline committee (2016-2018) and was a board member of British Society for Heart Failure.
Dr Moore has provided cardiovascular clinical support to local commissioning organisations for over two decades and to Cardiac Networks in the South-West. He is currently Clinical Co-Lead (Primary Care) for the West of England Integrated Cardiac Clinical Network.
Dr Moore is the National Clinical Co- Lead (Primary Care) for the National Cardiac Transformation Programme which has included working closely on NHSE initiatives such as Managing Heart Failure @Home and more recently chaired a group that developed the National (NHSE) guidance for the Virtual Ward care for people with heart failure.
He has been involved in the establishment and subsequent development of the community-based Gloucestershire Heart Failure service since its inception in 2003 where he continues to work as a GPSI.
Prof Clare Taylor
Professor of General Practice at the University of Birmingham
Clare Taylor is Professor of General Practice at the University of Birmingham and a GP in the NHS. Her research focuses on earlier diagnosis and improving prognosis for people with heart failure in primary care. She has received grant and fellowship funding from the National Institute for Health and Care Research, Wellcome Trust, and British Heart Foundation. She has published over 100 peer-reviewed papers in high impact journals, including British Medical Journal and European Heart Journal, and her research has informed international heart failure guidelines. She also held senior leadership positions at the Royal College of General Practitioners as Chair of their Associates in Training Committee and Lead of the First5 initiative. Clare was made a Member of the Order of the British Empire for services to General Practice in 2015.
Dr Lisa Anderson
Consultant Cardiologist at St George’s Hospital, London
Dr Anderson chairs the British Society for Heart Failure, the NHS England Heart Failure Expert Advisory Group and the ESC HFA Women in HF Taskforce.
Dr Anderson led the project to open the UK's first Acute Heart Failure Unit and wrote the proposal for the NCEPOD enquiry into deaths in Acute Heart Failure (2018).
Dr Anderson has acted as clinical expert for NICE Technology Appraisals (TA10946, TA10942, TA388) and the BMA Expert Review Group for TA267.
Dr Anderson has research Interests in V122I TTR cardiac amyloid, cardiorenal HF and acute heart failure.
Dr Anderson’s subspecialty is CMR. Dr Anderson developed a T2* sequence for the detection of cardiac iron, and the paper remains one of the most cited in the field. CMR T2* led rapidly to 70% mortality reduction in Thalassaemia patients in the UK. The T2* sequence is now the International Standard and installed on all CMR scanners from all vendors.
Beverley Bostock
PCCS President Elect, Advanced Nurse Practitioner, Mann Cottage Surgery and Editor in Chief, Practice Nurse Journal
Bev is an Advanced Nurse Practitioner in long-term conditions. She is currently President Elect of the Primary Care Cardiovascular Society. She has a special interest in cardiovascular disease (CVD), diabetes, heart failure, chronic kidney disease and lipid management along with common comorbidities such as metabolic liver disease, asthma and COPD. She is Editor in Chief of Practice Nurse Journal and has been a Queen’s Nurse since 2015.
In a previous role she developed and delivered accredited modules in cardiovascular disease, heart failure and diabetes in collaboration with the Open University. As well as holding an MA in Medical Ethics and Law and an MSc in Respiratory Care, Bev has a PgDip in Diabetes from the University of Warwick. Bev has had an extensive range of articles published in various journals on the management of long-term conditions and is a regular speaker at national conferences.
Dr Sundhya Raman
PCCS Lifestyle Medicine Representative, BSc (hons) MBBS DPhil (Oxon) Dipl IBLM/BSLM
Dr Sundhya Raman is a medical doctor (Guys, Kings and St Thomas’s, 2007) with a BSc in Pharmacology & Physiology, a PhD (DPhil) in Genetics/Epigenetics is qualified in Lifestyle Medicine with the International Board of Lifestyle Medicine and the British Society of Lifestyle Medicine.
She began her career as a clinical scientist, and aside from her DPhil at Oxford she worked in labs around the world including at Yale, University of Sydney and at the Wolfson Centre for Age Related Diseases, London.
Dr Raman is the founder and director of a lifestyle medicine health consultancy (My Wellness Doctor) which provides advice and support to educate and empower individuals to prevent illness, reverse disease, and optimise mental and physical wellbeing using evidence-based lifestyle modalities.
She has created a programme using lifestyle change to lower cholesterol in a primary care setting, and is the lead for virtual group consultations for diabetes at Plant Based Health Online.
Dr Raman regularly presents talks and teaching on lifestyle medicine and healthy ageing to both medical professionals (GP registrars, medical students, MIMs Learning Live, PCN training events) as well as to the lay public, including a focus on specific risks and solutions for BAME groups. She authored the diet section for JBS4 and co-authored the section on physical activity. She contributes to media publications on lifestyle advice to prevent chronic disease.
This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.
Prices
This event is free for all delegates.
This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.
Delegate Terms and Conditions
DATA PROTECTION
The data you have provided for this registration is stored and your name, organisation, job title and location details ONLY are shared with PCCS, the speaker faculty and funding company - see declaration - of this conference for attendance reporting purposes alone. LCW Consulting Ltd will use your data to contact you with regards to this conference only unless you have opted in for future events information. If you wish to cancel your registration, change your data options or require further information on our data policies please email registrations@lcwmed.co.uk or call via the registration number 0330 174 1090.
CHANGING DELEGATE DETAILS
There will be no charge if a substitute person wishes to replace the original delegate. Please inform our office at registrations@lcwmed.co.uk of any change to the original booking.
EVENT CANCELLATION POLICY
The PCCS' courses are constantly updated and improved and the PCCS reserves the right to alter any of the courses’ content without prior notice. The PCCS reserves the right to cancel a course at any time without liability. In these circumstances, delegates will be offered an alternative date if possible.
CANCELLATION OF REGISTRATION
The PCCS reserve the right to cancel or refuse any registration at our sole discretion if the registrant does not meet the eligibility or participation criteria. In such cases, any registration fees paid will be refunded; however, we will not be responsible for, nor will we reimburse, any costs incurred for travel, accommodation, or other related expenses.
This programme has been organised by PCCS and funded by Bayer plc. Bayer plc were not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the symposium sessions, for which Bayer plc is fully responsible.